Gempharmatech Co. Ltd. A (688046) — Financial Flexibility Index
Gempharmatech Co. Ltd. A (688046) has a Financial Flexibility Index of 0.47x as of December 2024. Free cash flow of CN¥203.99 Million (operating CF CN¥90.31 Million minus capex CN¥113.68 Million) represents 0% of total liabilities (CN¥437.92 Million). Check Gempharmatech Co. Ltd. A cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gempharmatech Co. Ltd. A Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Gempharmatech Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see Gempharmatech Co. Ltd. A (688046) cash conversion ratio.
Annual Financial Flexibility Index for Gempharmatech Co. Ltd. A (2019–2024)
Year-by-year free cash flow to debt coverage for Gempharmatech Co. Ltd. A. Explore 688046 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.47x | CN¥203.99 Million | CN¥90.31 Million | CN¥437.92 Million | ▼ -34.6% |
| 2023 | 0.71x | CN¥322.47 Million | CN¥116.57 Million | CN¥452.93 Million | ▼ -33.7% |
| 2022 | 1.07x | CN¥296.29 Million | CN¥105.98 Million | CN¥276.00 Million | ▲ +42.6% |
| 2021 | 0.75x | CN¥202.39 Million | CN¥113.31 Million | CN¥268.78 Million | ▼ -42.7% |
| 2020 | 1.31x | CN¥296.85 Million | CN¥129.79 Million | CN¥225.95 Million | ▲ +75.1% |
| 2019 | 0.75x | CN¥110.78 Million | CN¥65.12 Million | CN¥147.66 Million | — |